GLP1R and endocrine system disorder: Since we may not have had sufficient information about patients’ previous medication such as glucagon-like peptide-1 receptor agonists and statins, which may influence the gut microbiota composition (Everard & Cani, 2014; Vieira-Silva et al., 2020), further multivariate analyses are required to explore the contribution of medication to the gut microbiota of patients with endocrine diseases.